SCHEMBL2362497

SCHEMBL2362497

Cc1nc2ccccn2c1[C]=O

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.54
NPSR1 Q6W5P4 4/20 0.50
ALDH1A1 P00352 5/20 0.49
RXFP1 Q9HBX9 1/20 0.49
KDM4E B2RXH2 4/20 0.49
GAA P10253 2/20 0.49
MAPK1 P28482 1/20 0.48
HSD17B10 Q99714 4/20 0.47
HPGD P15428 3/20 0.47
NPC1 O15118 2/20 0.47
GLA P06280 2/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TP53 P04637 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL953657 0.82 KMT2A (0.50) KMT2ANPSR1ALDH1A1RXFP1KDM4E
SCHEMBL266148 0.75 KMT2A (0.58) KMT2ANPSR1ALDH1A1KDM4EGAA
SCHEMBL15004608 0.73 KMT2A (0.61) KMT2ANPSR1ALDH1A1KDM4EGAA
SCHEMBL11357473 0.73 KMT2A (0.56) KMT2ANPSR1ALDH1A1KDM4EGAA
SCHEMBL15004600 0.72 NPC1 (0.58) KMT2ANPSR1ALDH1A1KDM4EGAA
SCHEMBL792006 0.72 KMT2A (0.59) KMT2ANPSR1ALDH1A1KDM4EGAA
SCHEMBL6479532 0.72 KMT2A (0.54) KMT2ANPSR1ALDH1A1KDM4EGAA
SCHEMBL18901345 0.72 KMT2A (0.54) KMT2ANPSR1ALDH1A1KDM4EGAA
SCHEMBL7965109 0.72 KMT2A (0.54) KMT2ANPSR1ALDH1A1KDM4EGAA
SCHEMBL18304943 0.72 KMT2A (0.54) KMT2ANPSR1ALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120116027-A1 PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS NOVO NORDISK A/S (DK) 2012-05-10 US claimed
EP-2356141-A1 PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS Novo Nordisk A/S (DK) 2011-08-17 EP claimed
WO-2010055135-A1 PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS NOVO NORDISK A/S (DK) 2010-05-20 WO claimed
US-20120116027-A1 PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS NOVO NORDISK A/S (DK) 2012-05-10 US disclosed
EP-2356141-A1 PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS Novo Nordisk A/S (DK) 2011-08-17 EP disclosed
WO-2010055135-A1 PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS NOVO NORDISK A/S (DK) 2010-05-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120116027-A1 PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS GHRHR, GHITM, GHSR KMT2A 3404/4885NPSR1 196/4885ALDH1A1 4603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.